SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-004943
Filing Date
2018-03-08
Accepted
2018-03-08 16:25:08
Documents
3
Period of Report
2018-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crsp-8k_20180308.htm 8-K 35452
2 EX-99.1 crsp-ex991_6.htm EX-99.1 221986
3 GRAPHIC g2018030819090147145987.jpg GRAPHIC 15083
  Complete submission text file 0001564590-18-004943.txt   279470
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 18676783
SIC: 2836 Biological Products, (No Diagnostic Substances)